Pharmacyclics, Inc. (NASDAQ:PCYC)
CAPS Rating:
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
Growing the love for investing
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Well, looks like Papa's got a brand new bag...of crap stocks and lookie lookie, Pharmacyclics is high up on that list!
Pharmacyclics...what can I say? Where else can you call a 16 patient first phase trial a resounding success and shoot your market capitalization up 60M in a matter of days? Have you produced a profit for your shareholders? No. Are you burning through your 33M in remaining cash? Yes. Can I ask yes or no questions all day? Sure.
This is going to be a story we're talking about in 9-18 months of a company who's stock plummetts 60-70% in one day because their "only" drug crapped out in trials.
UltraLong
During the time it took you to write your BS, this stock jumped another $.50
You have no clue what you are talking about with PCYC.
....said the man with the sub 20 rating
I'll be back to notate your arrogance when this opens at $1.30 one day because their only drug failed in clinical trials
UltraLong
mailibusunsetter,
I have to tell you that I owned PCYC in 2000. Anyway, I am a chemical engineer who has done a bit of formulation development with unusual things so reading patents and understanding technology is one edge I have over a lot of people (I have 14 patents and 39 applications under examination). I love the idea of generating singlet oxygen from exposure with light. I was a FIRM believer in their technology. About 3 months after I bought this stock-
FIVE MAJOR LABORATORIES CAME OUT AND SAID THAT THEY COULD NOT REPEAT PHARMACYCLICS WORK!
Take a look at the chart, it went over 80 that year. Now you know why it dropped. If you don't believe me, you should give their investor relations department a call and see what they have to say about it. I could not find any links to information on it. If I were you, I'd avoid this dog like the plague!
bulwnkl
Boy, your analysis was impeccable! - Let's see, you were wrong on EVERY count.
This ones gotta hurt. Perhaps if you bought now, since we are still near the bottom, you might feel better in another year.
Should have listened to Malibusunsetter.